Status:
COMPLETED
Ocular Mysathenia Gravis Generalization
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Ocular Myasthenia Gravis
Eligibility:
All Genders
Brief Summary
Secondary ocular myasthenia gravis (OMG) generalization represents a pejorative evolution and no validated generalization prevention strategy exists. The aim of this observational study was to determi...
Eligibility Criteria
Inclusion
- \- Patients with OMG diagnosis and its generalization who consulted between January 1990 to January 2017 at Fondation Hospital Adolphe de Rothschild and registered in the database
Exclusion
- \- OMG differential diagnoses
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT04667650
Start Date
January 1 2017
End Date
January 1 2020
Last Update
December 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antoine GUEGUEN
Paris, France